Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus

Andreas B Petersen,1 Mikkel Christensen1,21Department of Clinical Pharmacology, Bispebjerg Hospital, Copenhagen, Denmark; 2Diabetes Research Division, Department of Internal Medicine, Gentofte Hospital, Copenhagen, DenmarkAbstract: The glucagon-like peptide (GLP)-1 receptor agonist lixisenatide (Lyx...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Petersen AB, Christensen M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Specialties of internal medicine
RC581-951
Acceso en línea:https://doaj.org/article/7b095839cdb5437283aae518cecf7f0c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares